PROVIDER PROFILE · NPI 1942305313

Elena Barengolts

EndocrinologyArlington Heights, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

218

Unique beneficiaries

—

Total services

354

Distinct HCPCS

Medicare payment

$28K

Peer benchmark

Total Medicare services vs. 262 Endocrinology providers in IL — bottom quintile (cohort median 1,061).

PRESCRIBING · PART D · 2024

Total Rx claims

3,074

Beneficiaries

—

Total drug cost

$1.1M

Distinct drugs

Brand share

44.8%

Top prescribed drugs

Glimepiride415 claims

Metformin Hcl344 claims

Pioglitazone Hcl314 claims

Semaglutide260 claims

Empagliflozin254 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

Travel and Lodging$14

REFERRAL NETWORK

Where Elena Barengolts's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Dan Mihailescu Endocrinology · Chicago, IL	49	104
Medstar Laboratory, Inc Clinical Laboratory · Hillside, IL	40	80
Future Diagnostics, Ltd. Independent Diagnostic Testing Facility (IDTF) · Chicago, IL	32	51
ENDEAVOR HEALTH CLINICAL OPERATIONS	29	67
Yuval Eisenberg Endocrinology · Chicago, IL	25	49
Anna Petrov Podiatry · Chicago, IL	14	23
Paul Heckerling Internal Medicine · Chicago, IL	13	44

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history